Cardiovascular

Impact of Balloon-Expandable Valve Asymmetry on Heart Failure Post Transcatheter Aortic Valve Replacement.

TL;DR

Fluoroscopic assessment of balloon-expandable valve expansion identified patients with marked valve asymmetry at increased risk of late heart failure after TAVR, despite preserved early valve performance.

Key Findings

Of 607 consecutive balloon-expandable valve TAVR patients in a prospective registry, 589 were analyzed, and 17% had heart failure hospitalization within 2 years.

  • 99 patients (17%) experienced HF hospitalization during follow-up.
  • Valve asymmetry was quantified with a fluoroscopic asymmetry index (%), defined as [(longest/shortest balloon-expandable valve height)-1]×100.
  • The primary end point was 2-year HF hospitalization.

As a continuous variable, the asymmetry index was not independently associated with 2-year HF hospitalization.

  • Adjusted HR per 1% increase was 1.02 (95% CI, 0.98-1.06).
  • Restricted cubic spline analysis showed no significant linear or nonlinear association (overall P=0.71; P for nonlinearity=0.89).
  • The risk curve nonetheless suggested increased HF risk beyond moderate valve asymmetry.

An exploratory threshold analysis identified an asymmetry index cutoff of 7.48%, above which 2-year HF hospitalization was more frequent.

  • HF hospitalization incidence was 23.6% above the threshold versus 15.8% below it (log-rank P=0.043).
  • The threshold analysis was described as exploratory.

The higher HF incidence in patients with greater asymmetry occurred despite comparable rates of impaired valve performance at discharge.

  • Rates of impaired valve performance at discharge were comparable between patients above and below the 7.48% threshold.
  • This suggests that early valve performance measures did not capture the risk associated with asymmetry.

Valve asymmetry >7.48% was independently associated with late HF occurring beyond 30 days after TAVR.

  • Adjusted HR was 1.69 (95% CI, 1.10-2.60).
  • The association was specific to late HF (beyond 30 days post-TAVR).

The authors conclude that intraprocedural fluoroscopic valve geometry assessment may help in long-term risk stratification, but needs further investigation.

  • Marked valve asymmetry identified patients at increased risk of late HF despite preserved early valve performance.
  • The findings are described as supporting the 'potential value' of intraprocedural assessment and warranting further investigation.

What This Means

This study looked at whether the shape of a replacement heart valve, as seen on X-ray imaging during a transcatheter aortic valve replacement (TAVR), relates to later heart failure. In 589 patients who received balloon-expandable valves, researchers measured how uneven the expanded valve looked (the difference between its tallest and shortest sides). About 17% of patients were hospitalized for heart failure within two years. When asymmetry was treated as a smooth scale, it was not clearly linked to heart failure hospitalization. But an exploratory analysis found that patients whose valves were more than about 7.5% asymmetric had more heart failure hospitalizations (23.6% vs 15.8%). This higher risk was seen for heart failure that occurred more than 30 days after the procedure, and it appeared even though standard valve performance checks at discharge looked similar between groups. This research suggests that how evenly a valve expands might carry information about long-term heart failure risk that routine early checks miss. However, the 7.48% cutoff came from an exploratory analysis in a single registry, so the findings need confirmation in further studies before they could be used to guide care.

Have a question about this study?

Citation

Kikuchi S, Trimaille A, Carmona A, Granier A, Kibler M, Truong D, et al.. (2026). Impact of Balloon-Expandable Valve Asymmetry on Heart Failure Post Transcatheter Aortic Valve Replacement.. Journal of the American Heart Association. https://doi.org/10.1161/JAHA.126.049304